Corient Private Wealth LP Purchases New Position in LeMaitre Vascular, Inc. $LMAT

Key Points

• Corient Private Wealth LP purchased 25,619 shares of LeMaitre Vascular worth approximately $2.46 million, while institutional investors collectively own 84.64% of the company.
• LeMaitre Vascular’s latest quarterly results missed expectations, with EPS of $0.74 versus the $0.81 consensus and revenue of $70.38 million versus estimates of $71.47 million. Revenue nonetheless increased 9.6% year over year.
• The company declared a quarterly dividend of $0.25 per share, equivalent to a $1.00 annualized payout and a 1.2% yield. Analysts’ consensus rating is Hold, with an average price target of $110.60.

Corient Private Wealth LP purchased a new stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 25,619 shares of the medical instruments supplier's stock, valued at approximately $2,458,000. Corient Private Wealth LP owned 0.11% of LeMaitre Vascular at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Illinois Municipal Retirement Fund increased its holdings in shares of LeMaitre Vascular by 1.1% during the 4th quarter. Illinois Municipal Retirement Fund now owns 11,171 shares of the medical instruments supplier's stock valued at $906,000 after purchasing an additional 123 shares in the last quarter. NewEdge Advisors LLC lifted its stake in shares of LeMaitre Vascular by 4.6% in the 4th quarter. NewEdge Advisors LLC now owns 3,158 shares of the medical instruments supplier's stock valued at $256,000 after purchasing an additional 139 shares during the period. Federated Hermes Inc. boosted its holdings in LeMaitre Vascular by 0.4% during the second quarter. Federated Hermes Inc. now owns 39,659 shares of the medical instruments supplier's stock worth $3,294,000 after buying an additional 155 shares in the last quarter. Pictet Asset Management Holding SA boosted its holdings in LeMaitre Vascular by 5.5% during the first quarter. Pictet Asset Management Holding SA now owns 3,259 shares of the medical instruments supplier's stock worth $356,000 after buying an additional 169 shares in the last quarter. Finally, Sound Income Strategies LLC grew its position in LeMaitre Vascular by 425.6% during the first quarter. Sound Income Strategies LLC now owns 226 shares of the medical instruments supplier's stock valued at $25,000 after buying an additional 183 shares during the period. Institutional investors and hedge funds own 84.64% of the company's stock.

LeMaitre Vascular Stock Up 0.8%

LMAT opened at $81.72 on Thursday. The company has a market cap of $1.87 billion, a PE ratio of 28.67, a price-to-earnings-growth ratio of 2.34 and a beta of 0.50. LeMaitre Vascular, Inc. has a twelve month low of $78.27 and a twelve month high of $118.01. The company has a 50-day moving average price of $92.45 and a 200 day moving average price of $99.28. The company has a quick ratio of 13.96, a current ratio of 16.31 and a debt-to-equity ratio of 0.40.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.07). LeMaitre Vascular had a return on equity of 15.63% and a net margin of 25.02%.The firm had revenue of $70.38 million during the quarter, compared to analyst estimates of $71.47 million. During the same quarter in the previous year, the firm posted $0.60 earnings per share. The company's quarterly revenue was up 9.6% on a year-over-year basis. Sell-side analysts expect that LeMaitre Vascular, Inc. will post 2.89 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.2%. LeMaitre Vascular's payout ratio is currently 35.09%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on LMAT shares. Zacks Research cut LeMaitre Vascular from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 6th. Citizens Jmp upped their price target on LeMaitre Vascular from $118.00 to $127.00 and gave the stock a "market outperform" rating in a report on Wednesday, May 6th. Wells Fargo & Company lowered their price target on LeMaitre Vascular from $104.00 to $94.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 5th. Weiss Ratings lowered LeMaitre Vascular from a "buy (b-)" rating to a "hold (c+)" rating in a report on Friday, August 14th. Finally, Citigroup restated a "market outperform" rating on shares of LeMaitre Vascular in a research report on Tuesday, July 21st. Three research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, LeMaitre Vascular has an average rating of "Hold" and a consensus target price of $110.60.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company's offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre's product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.

Want to see what other hedge funds are holding LMAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source